Search Results - "KRAFT, Andrew S"
-
1
The 2014 Surgeon General's report: “The Health Consequences of Smoking–50 Years of Progress”: A paradigm shift in cancer care
Published in Cancer (01-07-2014)“…To the authors' knowledge, the 2014 Surgeon General's report “The Health Consequences of Smoking‐50 Years of Progress” provides the first large evidence review…”
Get full text
Journal Article -
2
OER‐073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma
Published in Cancer (01-10-2022)“…Background Angiosarcomas are rare mesenchymal sarcomas that can present as primary cutaneous or noncutaneous disease. They express a variety of vascular…”
Get full text
Journal Article -
3
Small-Molecule-Targeting Hairpin Loop of hTERT Promoter G-Quadruplex Induces Cancer Cell Death
Published in Cell chemical biology (15-08-2019)“…Increased telomerase activity is associated with malignancy and poor prognosis in human cancer, but the development of targeted agents has not yet provided…”
Get more information
Journal Article -
4
PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species
Published in Molecular cancer therapeutics (01-07-2016)“…Intratumoral hypoxia is a significant obstacle to the successful treatment of solid tumors, and it is highly correlated with metastasis, therapeutic…”
Get full text
Journal Article -
5
Angiosarcoma treated successfully with anti-PD-1 therapy - a case report
Published in Journal for immunotherapy of cancer (18-07-2017)“…Angiosarcomas are tumors of malignant endothelial origin that have a poor prognosis with a five-year survival of less than 40%. These tumors can be found in…”
Get full text
Journal Article -
6
Elevation of Receptor Tyrosine Kinases by Small Molecule AKT Inhibitors in Prostate Cancer Is Mediated by Pim-1
Published in Cancer research (Chicago, Ill.) (01-06-2013)“…The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult. In particular, the antitumor activity…”
Get full text
Journal Article -
7
Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
Published in Journal of clinical oncology (01-07-2009)“…PURPOSE Since activity of sorafenib was observed in sarcoma patients in a phase I study, we performed a multicenter phase II study of daily oral sorafenib in…”
Get full text
Journal Article -
8
Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial
Published in The lancet oncology (01-04-2013)“…Summary Background Preclinical studies have shown synergistic antitumour activity by inhibition of insulin-like growth factor-1 receptor (IGF-1R) and mTOR. The…”
Get full text
Journal Article -
9
Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases
Published in Journal of medicinal chemistry (08-01-2009)“…The Pim protein kinases are frequently overexpressed in prostate cancer and certain forms of leukemia and lymphoma…”
Get full text
Journal Article -
10
Pim protein kinases regulate energy metabolism and cell growth
Published in Proceedings of the National Academy of Sciences - PNAS (11-01-2011)“…The serine/threonine Pim kinases are overexpressed in solid cancers and hematologic malignancies and promote cell growth and survival. Here, we find that a…”
Get full text
Journal Article -
11
EDC3 phosphorylation regulates growth and invasion through controlling P-body formation and dynamics
Published in EMBO reports (07-04-2021)“…Regulation of mRNA stability and translation plays a critical role in determining protein abundance within cells. Processing bodies (P-bodies) are critical…”
Get full text
Journal Article -
12
PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth
Published in Molecular oncology (01-05-2020)“…The proviral integration site for Moloney murine leukemia virus (PIM) serine/threonine kinases have an oncogenic and prosurvival role in hematological and…”
Get full text
Journal Article -
13
The Pim-1 Protein Kinase Is an Important Regulator of MET Receptor Tyrosine Kinase Levels and Signaling
Published in Molecular and cellular biology (01-07-2014)“…MET, the receptor for hepatocyte growth factor (HGF), plays an important role in signaling normal and tumor cell migration and invasion. Here, we describe a…”
Get full text
Journal Article -
14
ABT-737 Induces Expression of the Death Receptor 5 and Sensitizes Human Cancer Cells to TRAIL-induced Apoptosis
Published in The Journal of biological chemistry (05-09-2008)“…Because Bcl-2 family members inhibit the ability of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis, we investigated…”
Get full text
Journal Article -
15
Collaboration of Kras and Androgen Receptor Signaling Stimulates EZH2 Expression and Tumor-Propagating Cells in Prostate Cancer
Published in Cancer research (Chicago, Ill.) (15-09-2012)“…Elevation of the chromatin repression factor enhancer of zeste homolog (EZH2) is associated with progression and poor prognosis in several human cancers…”
Get full text
Journal Article -
16
PIM1 Protein Kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells
Published in Cancer biology & therapy (01-05-2009)“…PIM1 is a serine /threonine kinase that has diverse biological roles in cell survival, proliferation and differentiation. PIM1 has been implicated in early…”
Get full text
Journal Article -
17
Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells
Published in Molecular cancer therapeutics (01-06-2009)“…The Pim protein kinases play important roles in cancer development and progression, including prostate tumors and hematologic malignancies. To investigate the…”
Get full text
Journal Article -
18
Proteasome inhibitor PS-341 (VELCADE) induces stabilization of the TRAIL receptor DR5 mRNA through the 3′-untranslated region
Published in Molecular cancer therapeutics (01-05-2008)“…Addition of proteasome inhibitor PS-341 (VELCADE, bortezomib) to prostate cancer cells enhances cell death mediated by tumor necrosis factor–related…”
Get full text
Journal Article -
19
Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report
Published in Journal of medical case reports (24-07-2021)“…Abstract Background Perivascular epithelioid cell tumors are defined by the World Health Organization as “a collection of rare mesenchymal tumors composed of…”
Get full text
Journal Article -
20
Pim1 Serine/Threonine Kinase Regulates the Number and Functions of Murine Hematopoietic Stem Cells
Published in Stem cells (Dayton, Ohio) (01-06-2013)“…The genes and pathways that govern the functions and expansion of hematopoietic stem cells (HSC) are not completely understood. In this study, we investigated…”
Get full text
Journal Article